MOMM Diagnostics GmbH

MOMM Diagnostics develops rapid, cost-effective diagnostic tests for pregnancy complications. préXclude® is our first test in development to diagnose and prognose preeclampsia a leading cause of death in pregnancy. Our innovative electrochemical lateral flow immunoassay enables early detection using a simple fingerstick blood sample, providing fast and reliable results at the point of care. By improving early diagnosis, we help reduce maternal and fetal risks, supporting better healthcare outcomes. Our primary customers include hospitals, clinics, and OB-GYNs, with a global maternal health market offering strong growth potential. MOMM aims to revolutionize prenatal care with accessible, high-performance diagnostics, addressing an urgent need for timely and affordable testing solutions.